Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing

Introduction

The paper situates itself within renewed scientific and popular interest in psychedelics and in mindfulness-based contemplative practices. Earlier clinical research has shown that high-dose psychedelics (notably psilocybin) can occasion mystical-type experiences that are followed by persistent improvements in measures such as life meaning, spirituality and psychological functioning, while formal mindfulness interventions (for example MBSR, MBCT) have demonstrated small-to-moderate improvements in stress, depression and anxiety. The authors note phenomenological and neurobiological overlap between deep meditation and psychedelic states (for instance reductions in default mode network activity) and point out that a small number of studies suggest combined use may yield additive benefits. However, naturalistic data on recreational psychedelic use, everyday mindfulness practice and their joint associations with multi-dimensional wellbeing remain limited. Qiu and colleagues set out to address that gap by testing whether trait mindfulness and psychedelic-mediated mystical experience are associated with a broad range of wellbeing outcomes in a large, non-clinical sample. The study pre-registered seven hypotheses on OSF and used hierarchical regression to test whether mindfulness and mystical experience predict affect, meaning in life, life satisfaction, wisdom and symptoms of depression, anxiety and stress, and whether psychedelic use moderates those relationships. The authors emphasise a naturalistic, cross-sectional approach to capture how people actually engage in meditation and recreational psychedelic use outside laboratory settings.